BERLIN—Swiss drugs regulator Swissmedic said on Wednesday it is examining potential risks in connection with bubbles that appeared in vials of COVID-19 vaccine boosters retooled to target the Omicron variant of the coronavirus. Swissmedic said it had been informed by vaccination centers of the appearance of bubbles during the preparation of the updated vaccine from…
Swissmedic Approves Roche’s Ronapreve to Treat COVID-19 Patients
December 27, 2021
admin
Business & EconomyCCP VirusCompaniesCOVID-19EuropeHealth NewsPUBLIC HEALTH INFORMATIONRocheRonapreveSwissmedicWorld
0 Comment
ZURICH—Swiss drugs regulator Swissmedic said on Monday it approved Ronapreve, an antibody treatment jointly developed by Roche and Regeneron, to treat COVID-19 patients. “In this procedure, no data on efficacy against the Omicron variant were submitted,” Swissmedic said in a statement. The antibody treatment was already authorized for prescription in Switzerland under COVID-19 Ordinance 3…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`